Temporal and epigenetic regulation of neural progenitor plasticity in Drosophila

The discovery of stem cells in the adult brain has triggered new hope for replacing neurons in the treatment of neurodegenerative disease. However, compared to the embryonic kind, adult neural stem cells (NSCs) multiply less and can mature into fewer cell types. Dr. Maurange’s work sheds light on the signals regulating an adult NSC’s fate. If this control system can be unraveled, the manipulation of adult stem cells to effectively treat neurodegenerative disorders may, indeed, prove possible.

New Perspectives for the Use of Adult Stem Cells in Neural Disease

In his own words

My research focuses on adult neural stem cells (NSCs) and, specifically, their use in treating age related neurodegenerative diseases, via the induced regeneration of lost neurons. The therapeutic use of the NSCs will require an understanding of how their potential/plasticity is regulated. I use Drosophila as a model system.

To add or modify information on this page, please contact us at the following address: community.research@axa.com

Cédric
MAURANGE

Institution

Université de la Méditerranée

Country

France

Nationality

French

ORCID Open Researcher and Contributor ID, a unique and persistent identifier to researchers

Health

Mental Health & Neurology

AXA Chair

Belgium

Neuropsychiatric Diseases and Basal Ganglia: Underlying Mechanisms

A central hub in the brain, the basal ganglia governs a diverse array of functions including voluntary movement, procedural memory, habit... Read more